Acceleron Pharma competitors

Acceleron Pharma Competitors include Creative Peptides, Ncardia, XOMA and Minerva Neurosciences.

Add company...

Save Comparison Clear all	Acceleron Pharma Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.	Creative Peptides Creative peptides is specialized in the process development and the manufacturing of bioactive peptides.	Ncardia Ncardia is a stem cell drug discovery and development company.	XOMA XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.	Minerva Neurosciences Minerva Neurosciences is a clinical-stage biopharmaceutical company.
Founding Date	Founding Date 2003	Founding Date 2004	Founding Date 2010	Founding Date 1981	Founding Date 2007
Type	Type Public	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development medtech pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Cambridge, US HQ	Locations Shirley, US HQ	Locations Gosselies, BE HQ Köln, DE Leiden, NL Plymouth Meeting, US	Locations Emeryville, US HQ	Locations Waltham, US HQ
Employees	Employees 13915% increase	Employees 4	Employees 602% increase	Employees 1878% decrease	Employees 129% increase
Valuation ($)	Valuation ($) 2.3 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 112.5 m	Valuation ($) 321.9 m
Twitter followers	Twitter followers 499	Twitter followers N/A	Twitter followers 566	Twitter followers 185	Twitter followers N/A
Financial ⚠
Revenue (est.)	Revenue (est.) $13.5m (FY, 2017)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $52.7m (FY, 2017)	Revenue (est.) N/A
Net income	Net income ($108.5m) (FY, 2017)	Net income N/A	Net income N/A	Net income N/A	Net income ($31.5m) (FY, 2017)
Funding
Total funding raised	Total funding raised $ 122.8m	Total funding raised N/A	Total funding raised $ 20.2m	Total funding raised N/A	Total funding raised $ 51.2m